FDA, Opdivo and Bristol Myers Squibb
Initially the hair spray brand was a voluntarily recalled by CRLAB USA, based in California, on Dec. 12 and became a Class II recall by the FDA on Dec. 26.
Each month, the U.S. Food and Drug Administration has halted food-and-drug related items for purchase. Most of the recalls are contamination or allergen-based. While 2025 is near,
Dichloromethane, a volatile solvent commonly used in industrial applications, has been banned in products in many areas, including the U.S. and the European Union, due to its potential health risks.
The US Food and Drug Administration has approved the first generic referencing Victoza (liraglutide; Hikma Pharmaceuticals), a glucagon-like peptide-1 (GLP-1) receptor agonist indicated to improve glycemic control in adults and pediatric patients aged 10 years and older with type 2 diabetes.
Axsome Therapeutics said it would submit its Alzheimer’s disease treatment for FDA approval despite mixed results from two new clinical trials.
In early December, the Supreme Court heard oral argument in Food and Drug Administration v. Wages and White Lion Investments, a challenge to the FDA's
The proposed rule is required under a law passed by Congress last year, and is intended to ensure the safety of makeup and baby powder.
BLAIR COUNTY, Pa (WJAC) — The U.S. Food and Drug Administration (FDA) has issued a temporary recall of the latest Gardners Candies' specialty candy bars. According to the announcement, the Blair County-based candy company is recalling its new "Cappuccino Meltaway" bars due to an undeclared tree nut allergen and packaging issue.
Whole grains and fruits are in, and added sugar is out. That’s going to change what’s on a lot of cereal boxes and other things
One lot of Systane Lubricant Eye Drops Ultra PF, manufactured by Alcon Laboratories, has been recalled due to fungal contamination, the FDA announced this week.
Stay updated on the latest developments in the GLP-1 drug class, including a new generic entering the market, weight loss results, FDA decisions & cost issues.